Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 736 AL 750

A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome

Wiseman FK, Al-Janabi T, Hardy J, Karmiloff-Smith A, Nizetic D, Tybulewicz VL, Fisher EM, Strydom A.

Nat Rev Neurosci. 2015 Sep;16(9):564-74. doi: 10.1038/nrn3983. Epub 2015 Aug 5.

Elevated galanin may predict the risk of type 2 diabetes mellitus for development of Alzheimer's disease

Zhang Z, Fang P, Shi M, Zhu Y, Bo P.

Mech Ageing Dev. 2015 Sep;150:20-6. doi: 10.1016/j.mad.2015.08.001. Epub 2015 Aug 4.

Mini-Mental State Examination for the Detection of Alzheimer Disease and Other Dementias in People With Mild Cognitive Impairment

Skorga P, Young CF.

Clin Nurse Spec. 2015 Sep-Oct;29(5):265-7. doi: 10.1097/NUR.0000000000000150.

EFFECT OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID SUPPLEMENTATIONS TO CONTROL COGNITIVE DECLINE IN DEMENTIA AND ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW

de Souza Fernandes DP, Canaan Rezende FA, Pereira Rocha G, De Santis Filgueiras M, Silva Moreira PR, Gonçalves Alfenas Rde C.

Nutr Hosp. 2015 Aug 1;32(2):528-33. doi: 10.3305/nh.2015.32.2.9111.

Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease

Liu CS, Chau SA, Ruthirakuhan M, Lanctôt KL, Herrmann N.

CNS Drugs. 2015 Aug;29(8):615-23. doi: 10.1007/s40263-015-0270-y.

Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer's dementia

Huang CW, Tsai MH, Chen NC, Chen WH, Lu YT, Lui CC, Chang YT, Chang WN, Chang AY, Chang CC.

Thromb Haemost. 2015 Nov 25;114(6):1230-40. doi: 10.1160/TH14-11-0938. Epub 2015 Aug 20.

Meta-analysis of modifiable risk factors for Alzheimer's disease

Xu W, Tan L, Wang HF, Jiang T, Tan MS, Tan L, Zhao QF, Li JQ, Wang J, Yu JT.

J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1299-306. doi: 10.1136/jnnp-2015-310548. Epub 2015 Aug 20.

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial

Rosenberg PB, Drye LT, Porsteinsson AP, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Weintraub D, Newell J, Yesavage J, Lyketsos CG; CitAD Research Group.

Int Psychogeriatr. 2015 Dec;27(12):2059-67. doi: 10.1017/S1041610215001106. Epub 2015 Aug 25.

Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies

Tromp D, Dufour A, Lithfous S, Pebayle T, Després O.

Ageing Res Rev. 2015 Nov;24(Pt B):232-62. doi: 10.1016/j.arr.2015.08.006. Epub 2015 Aug 28.

Interventions for Neuropsychiatric Symptoms in Neurocognitive Impairment Due to Alzheimer's Disease: A Review of the Literature

McClam TD, Marano CM, Rosenberg PB, Lyketsos CG.

Harv Rev Psychiatry. 2015 Sep-Oct;23(5):377-93. doi: 10.1097/HRP.0000000000000097.

Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services

Wattmo C, Londos E, Minthon L.

Dement Geriatr Cogn Disord. 2015;40(5-6):297-310. doi: 10.1159/000437050. Epub 2015 Sep 4.

Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline

Walker JM, Harrison FE.

Nutrients. 2015 Sep 1;7(9):7332-57. doi: 10.3390/nu7095341.

Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease?

Dekker AD, Strydom A, Coppus AM, Nizetic D, Vermeiren Y, Naudé PJ, Van Dam D, Potier MC, Fortea J, De Deyn PP.

Cortex. 2015 Dec;73:36-61. doi: 10.1016/j.cortex.2015.07.032. Epub 2015 Aug 13.

Alzheimer's disease and language impairments: social intervention and medical treatment

Klimova B, Maresova P, Valis M, Hort J, Kuca K.

Clin Interv Aging. 2015 Aug 27;10:1401-7. doi: 10.2147/CIA.S89714. eCollection 2015.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias